Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal, 26(14), 1816–1821. https://doi.org/10.1177/1352458520970841

Article  PubMed  Google Scholar 

Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1444. https://doi.org/10.1212/WNL.33.11.1444

Article  CAS  PubMed  Google Scholar 

Uitdehaag, B. M. J. (2018). Disability outcome measures in phase III clinical trials in multiple sclerosis. Cns Drugs, 32(6), 543–558. https://doi.org/10.1007/s40263-018-0530-8

Article  PubMed  PubMed Central  Google Scholar 

Fayers, P. M., & Machin, D. (2013). Quality of life: The assessment, analysis and interpretation of patient-reported outcomes. Wiley.

Brazier, J. (2008). Valuing Health states for Use in cost-effectiveness analysis. Pharmacoeconomics, 26(9), 769–779. https://doi.org/10.2165/00019053-200826090-00007

Article  PubMed  Google Scholar 

Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736. https://doi.org/10.1007/s11136-011-9903-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuspinar, A., & Mayo, N. E. (2014). A review of the Psychometric properties of Generic Utility measures in multiple sclerosis. Pharmacoeconomics, 32(8), 759–773. https://doi.org/10.1007/s40273-014-0167-5

Article  PubMed  Google Scholar 

Zhou, T., Guan, H., Wang, L., Zhang, Y., Rui, M., & Ma, A. (2021). Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: A systematic review. Frontiers in Public Health, 9, 675523. https://doi.org/10.3389/fpubh.2021.675523

Article  PubMed  PubMed Central  Google Scholar 

Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., Eriksson, J., & the MSCOI Study Group, & the European Multiple Sclerosis Platform. (2017). New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal, 23(8), 1123–1136. https://doi.org/10.1177/1352458517694432

Article  PubMed  Google Scholar 

Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4(3), 187–206. https://doi.org/10.1007/BF02260859

Article  CAS  PubMed  Google Scholar 

Hobart, J. (2001). The multiple sclerosis impact scale (MSIS-29): A new patient-based outcome measure. Brain, 124(5), 962–973. https://doi.org/10.1093/brain/124.5.962

Article  CAS  PubMed  Google Scholar 

Kennedy-Martin, M., Slaap, B., Herdman, M., Van Reenen, M., Kennedy-Martin, T., Greiner, W., & Boye, K. S. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics, 21(8), 1245–1257. https://doi.org/10.1007/s10198-020-01195-8

Article  PubMed  PubMed Central  Google Scholar 

Abdelhak, A., Antweiler, K., Kowarik, M. C., Senel, M., Havla, J., Zettl, U. K., & Tumani, H. (2024). Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis. Multiple Sclerosis and Related Disorders, 81, 105139. https://doi.org/10.1016/j.msard.2023.105139

Article  PubMed  Google Scholar 

Visser, L. A., Louapre, C., Uyl-de Groot, C. A., & Redekop, W. K. (2021). Health-related quality of life of multiple sclerosis patients: A European multi-country study. Archives of Public Health = Archives Belges De Sante Publique, 79(1), 39. https://doi.org/10.1186/s13690-021-00561-z

Article  PubMed  PubMed Central  Google Scholar 

Twork, S., Wiesmeth, S., Spindler, M., Wirtz, M., Schipper, S., Pöhlau, D., & Kugler, J. (2010). Disability status and quality of life in multiple sclerosis: Non-linearity of the expanded disability status scale (EDSS). Health and Quality of Life Outcomes, 8(1), 55. https://doi.org/10.1186/1477-7525-8-55

Article  PubMed  PubMed Central  Google Scholar 

Gil-González, I., Martín-Rodríguez, A., Conrad, R., & Pérez-San-Gregorio, M. Á. (2020). Quality of life in adults with multiple sclerosis: A systematic review. British Medical Journal Open, 10(11), e041249. https://doi.org/10.1136/bmjopen-2020-041249

Article  Google Scholar 

Zhang, Y., Taylor, B. V., Simpson, S., Blizzard, L., Campbell, J. A., Palmer, A. J., & Van Der Mei, I. (2021). Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype. Multiple Sclerosis Journal, 27(8), 1262–1275. https://doi.org/10.1177/1352458520958369

Article  PubMed  Google Scholar 

Zettl, U. K., Henze, T., Essner, U., & Flachenecker, P. (2014). Burden of disease in multiple sclerosis patients with spasticity in Germany: Mobility improvement study (move I). The European Journal of Health Economics, 15(9), 953–966. https://doi.org/10.1007/s10198-013-0537-5

Article  PubMed  Google Scholar 

Zecca, C., Riccitelli, G. C., Disanto, G., Singh, A., Digesu, G. A., Panicari, L., & Gobbi, C. (2016). Urinary incontinence in multiple sclerosis: Prevalence, severity and impact on patients’ quality of life. European Journal of Neurology, 23(7), 1228–1234. https://doi.org/10.1111/ene.13010

Article  CAS  PubMed  Google Scholar 

Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., & Cohen, J. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 17(2), 162–173. https://doi.org/10.1016/S1474-4422(17)30470-2

Article  PubMed  Google Scholar 

Ahmad, H., Campbell, J. A., Van Der Mei, I., Taylor, B. V., Xia, Q., Zhao, T., & Palmer, A. J. (2023). Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: Implications for health economic evaluation models. Quality of Life Research, 32(12), 3373–3387. https://doi.org/10.1007/s11136-023-03486-y

Article  PubMed  PubMed Central  Google Scholar 

Elm, E. V., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Bmj, 335(7624), 806–808. https://doi.org/10.1136/bmj.39335.541782.AD

Article  Google Scholar 

Ludwig, K., Schulenburg, G. V. D., J.-M., & Greiner, W. (2018). German value set for the EQ-5D-5L. Pharmacoeconomics, 36(6), 663–674. https://doi.org/10.1007/s40273-018-0615-8

Article  PubMed  PubMed Central  Google Scholar 

edmus_fs.pdf (n.d.). Retrieved from https://www.edmus.org/en/dl/scales/edmus_fs.pdf

Skjerbæk, A. G., Boesen, F., Petersen, T., Rasmussen, P. V., Stenager, E., Nørgaard, M., & Dalgas, U. (2019). Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? Multiple Sclerosis Journal, 25(12), 1653–1660. https://doi.org/10.1177/1352458518795416. The Danish MS hospitals rehabilitation study.

Article  PubMed  Google Scholar 

Walter, S. D., Feinstein, A. R., & Wells, C. K. (1987). CODING ORDINAL INDEPENDENT VARIABLES IN MULTIPLE REGRESSION ANALYSES. American Journal of Epidemiology, 125(2), 319–323. https://doi.org/10.1093/oxfordjournals.aje.a114532

Article  CAS  PubMed  Google Scholar 

R Core Team (2022). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from https://www.R-project.org/

RStudio Team (2022). RStudio: Integrated Development Environment for R. Boston, MA: RStudio, PBC. Retrieved from http://www.rstudio.com/

Henry, E. B., Barry, L. E., Hobbins, A. P., McClure, N. S., & O’Neill, C. (2020). Estimation of an instrument-defined minimally important difference in EQ-5D-5L Index scores based on Scoring algorithms Derived using the EQ-VT version 2 valuation protocols. Value in Health, 23(7), 936–944. https://doi.org/10.1016/j.jval.2020.03.003

Article  PubMed  Google Scholar 

Fambiatos, A., Jokubaitis, V., Horakova, D., Kubala Havrdova, E., Trojano, M., Prat, A., & Kalincik, T. (2020). Risk of secondary progressive multiple sclerosis: A longitudinal study. Multiple Sclerosis Journal, 26(1), 79–90. https://doi.org/10.1177/1352458519868990

Article  PubMed  Google Scholar 

McGinley, M. P., Goldschmidt, C. H., & Rae-Grant, A. D. (2021). Diagnosis and treatment of multiple sclerosis: A review. Journal of the American Medical Association, 325(8), 765–779. https://doi.org/10.1001/jama.2020.26858

Article  CAS  PubMed  Google Scholar 

Marten, O., & Greiner, W. (2021). EQ-5D-5L reference values for the German general elderly populat